CHICAGO (GenomeWeb) – Sophia Genetics has closed on a $30 million Series D round of venture capital, the Swiss genomic analytics company announced today.

UK-based Balderton Capital led the round, with participation from 360° Capital Partners and previous Sophia Genetics investors Invoke Capital and Alychlo.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.